This panel will examine how artificial intelligence is expected to shape oncology care delivery, research and operations in the coming years. Speakers will discuss where AI is showing the most promise today, as well as the technical, clinical and organizational barriers that may limit broader adoption. The conversation will also explore how oncology leaders are thinking about governance, validation and responsible use as these tools continue to evolve.